Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Tretinoin and Fenretinide

supplement:

Tretinoin

Research Papers that Mention the Interaction

Pre-treatment of neuroblastoma cell lines with retinoic acid RA ) resulted in a significant decrease in the apoptotic response to fenretinide in three of the four lines tested.
The interaction between RA and fenretinide could have important implications for the scheduling of fenretinide in therapeutic protocols for neuroblastoma.
Oncology reports  •  2012  |  View Paper
The levels of the retinoid receptors, retinoic acid receptor alpha and retinoid X receptor gamma, were up-regulated in response to fenretinide , suggestive of ligand-induced receptor up-regulation.
Cancer research  •  2005  |  View Paper
N-(4-hydroxyphenyl) retinamide (Fenretinide, 4-HPR) inhibits cell growth by inducing apoptosis in numerous tumor cell types including all-trans-retinoic acid (ATRA)-resistant tumor cells.
Leukemia & lymphoma  •  2004  |  View Paper
After 30 minutes of RA and 4HPR (10(-7) mol/L) exposure, a 20% decrease of basal cAMP accumulation was seen, and forskolin cAMP-induced increase was abolished.
Metabolism: clinical and experimental  •  2003  |  View Paper
At 1.3 µM concentration (a clinically pharmacologically achievable dose), 4HPR increased ATRA sensitivity synergistically in HER2/neu-overexpressing BT-474, MDA-MB-453, and MCF-7/Her2 breast cancer cells.
Combining 4HPR with ATRA may lead to a novel, selective therapeutic or chemopreventive strategy against HER2/neu-overexpressing breast tumors.
Tumor Biology  •  2002  |  View Paper
HPR exposure resulted in time-dependent increase in cellular metabolism of the retinoid as evidenced by increased formation of the inert metabolite N-(4-methoxyphenyl)-retinamide (MPR) and progressive increase in apoptosis.
Carcinogenesis  •  1999  |  View Paper
The antiproliferative effect of HPR was, in all cell lines except K422, more potent than that induced by an equimolar dose of all-trans retinoic acid (RA).
Cancer research  •  1993  |  View Paper
Abnormal retinal function has been reported in patients receiving the synthetic retinoid fenretinide.
Journal of ocular pharmacology  •  1988  |  View Paper
In addition, we have tested the hypothesis that vimentin expression after HPR and RA , taken as indirect evidence of the mechanisms of action of the two retinoids, may be different.
International journal of oncology  •  1995  |  View Paper